Chronic lymphocytic leukemia with MDM2 amplification as an alternative pathway to TP53 dysfunction

被引：0
|
作者：
Hunter, Sally [1 ,6 ]
Ryland, Georgina [1 ,2 ,6 ]
Pang, Jia-Min [1 ,6 ]
Ninkovic, Slavisa [3 ]
Dun, Karen [3 ,4 ]
Seymour, John F. [5 ,7 ]
Blombery, Piers [1 ,2 ,5 ,6 ]
机构：
[1] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Australia
[3] St Vincents Hosp Melbourne, Victorian Canc Cytogenet Serv, Melbourne, Vic, Australia
[4] St Vincents Hosp Melbourne, Dept Haematol, Melbourne, Vic, Australia
[5] Peter MacCallum Canc Ctr, Clin Haematol, Melbourne, Vic, Australia
[6] Royal Melbourne Hosp, Melbourne, Vic, Australia
[7] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia
来源：
LEUKEMIA & LYMPHOMA | 2024年 / 65卷 / 14期
关键词：
D O I：
10.1080/10428194.2024.2398659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2215 / 2218
页数：4
相关论文
共 50 条
  • [41] ALTERED PATTERNS OF MDM2 AND TP53 EXPRESSION IN HUMAN BLADDER-CANCER
    LIANES, P
    ORLOW, I
    ZHANG, ZF
    OLIVA, MR
    SARKIS, AS
    REUTER, VE
    CORDONCARDO, C
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (17) : 1325 - 1330
  • [42] Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating TP53 Wild-Type Chronic Lymphocytic Leukemia
    Aptullahoglu, Erhan
    Howladar, Mohammed
    Wallis, Jonathan P.
    Marr, Helen
    Marshall, Scott
    Irving, Julie
    Willmore, Elaine
    Lunec, John
    CANCERS, 2025, 17 (02)
  • [43] Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancer
    Hashemi, Mohammad
    Amininia, Shadi
    Ebrahimi, Mahboubeh
    Simforoosh, Nasser
    Basiri, Abbas
    Ziaee, Seyed Amir Mohsen
    Narouie, Behzad
    Sotoudeh, Mehdi
    Mollakouchekian, Mohammad Javad
    Maleki, Esmaeil Rezghi
    Hanafi-Bojd, Hamideh
    Rezaei, Maryam
    Bahari, Gholamreza
    Taheri, Mohsen
    Ghavami, Saeid
    ONCOLOGY LETTERS, 2017, 13 (04) : 2483 - 2489
  • [44] Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer
    Ashton, Katie A.
    Proietto, Anthony
    Otton, Geoffrey
    Symonds, Ian
    McEvoy, Mark
    Attia, John
    Gilbert, Michael
    Hamann, Ute
    Scott, Rodney J.
    GYNECOLOGIC ONCOLOGY, 2009, 113 (01) : 109 - 114
  • [45] Genetic variants in TP53 and MDM2 associated with male infertility in Chinese population
    Huang, Cong
    Liu, Wei
    Ji, Gui-Xiang
    Gu, Ai-Hua
    Qu, Jian-Hua
    Song, Ling
    Wang, Xin-Ru
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (05) : 691 - 694
  • [46] Gene abnormalities in multiple myeloma;: the relevance of TP53, MDM2, and CDKN2A
    Elnenaei, MO
    Gruszka-Westwood, AM
    A'Hern, R
    Matutes, E
    Sirohi, B
    Powles, R
    Catovsky, D
    HAEMATOLOGICA, 2003, 88 (05) : 529 - 537
  • [47] TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia
    Hua-Jie Dong
    Cheng Fang
    Li Wang
    Lei Fan
    Ji Xu
    Jia-Zhu Wu
    Ting-Xun Lu
    Jian-Yong Li
    Wei Xu
    Medical Oncology, 2014, 31
  • [48] TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia
    Dong, Hua-Jie
    Fang, Cheng
    Wang, Li
    Fan, Lei
    Xu, Ji
    Wu, Jia-Zhu
    Lu, Ting-Xun
    Li, Jian-Yong
    Xu, Wei
    MEDICAL ONCOLOGY, 2014, 31 (04)
  • [49] MDM2 Oncogene Copy Number Alterations in Chronic Lymphocytic Leukemia
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (03) : 220 - 220
  • [50] Status Analysis of the Genes MYCN, MDM2 and TP53 and Protein Expression of MDM2, P53 and PRB in Patients with Retinoblastoma Underwent Enucleation
    Carvalho Filho, N.
    Cunha, I. Werneck
    Ribeiro, K. Braga
    Antoneli, C. B. Gianotti
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S144 - S144
12345